November 9, 2012: Nonprescription Drugs Advisory Committee Meeting Announcement
UPDATED LOCATION AND WEBCAST INFORMATION: November 9, 2012: Nonprescription Drugs Advisory Committee Meeting Announcement
Updated Information (as of 10/5/2012):
The location for this meeting has changed from the DoubleTree by Hilton Hotel Washington DC/Silver Spring, The Ballrooms, 8727 Colesville Road, Silver Spring, Maryland to FDA White Oak Campus, Building 31, The Great Room (Rm. 1503), White Oak Conference Center, 10903 New Hampshire Avenue, Silver Spring, Maryland. Also, CDER now plans to provide a free of charge, live webcast of the meeting. All other information remains the same.
|CDER||November 9, 2012||8:00 a.m. - 5:00 p.m.|
FDA White Oak Campus
Information regarding ground transportation, airport information, lodging, driving directions and visitor parking, and security can be accessed at: Public Meetings at the FDA White Oak Campus.
CDER plans to provide a free of charge, live webcast of the November 9, 2012, meeting of the Nonprescription Drugs Advisory Committee. While CDER is working to make webcasts available to the public for all advisory committee meetings held at the White Oak campus, there are instances where the webcast transmission is not successful; staff will work to re-establish the transmission as soon as possible. Further information regarding the webcast, including the web address for the webcast, will be made available at least 2 days in advance of the meeting at the following website: 2012 Meeting Materials, Nonprescription Drugs Advisory Committee
CDER plans to post archived webcasts after the meeting, however, in cases where transmission was not successful, archived webcasts will not be available.
UPDATED CONTACT INFORMATION: November 9, 2012: Nonprescription Drugs Advisory Committee Meeting Announcement
Updated Information (as of 9/26/2012):
The contact person for this meeting has changed from Glendolynn S. Johnson to Minh Doan. All other information remains the same.
The contact information should be updated to read as follows:
- Minh Doan, Pharm.D.
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993-0002
- FDA Advisory Committee Information Line
(301-443-0572 in the Washington DC area)
Please call the Information Line for up-to-date information on this meeting.
A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Web site and call the FDA Advisory Committee Information Line to learn about possible modifications before coming to the meeting.
Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Minh Doan at (301) 796-9001 at least 7 days in advance of the meeting.
|CDER||November 9, 2012||8:00 a.m. to 5:00 p.m.|
DoubleTree by Hilton Hotel
Washington DC/Silver Spring
8727 Colesville Road
- Written submissions may be made to the contact person on or before October 26, 2012.
- Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before October 18, 2012.